JAGSONPAL PHARMACEUTICALS
Back to Balance Sheet
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Sundry Debtors | ₹11 Cr | ₹21 Cr | ₹16 Cr | ₹13 Cr | ₹21 Cr |
What is the latest Sundry Debtors ratio of JAGSONPAL PHARMACEUTICALS ?
Year | Sundry Debtors |
---|---|
Mar2024 | ₹11 Cr |
Mar2023 | ₹21 Cr |
Mar2022 | ₹16 Cr |
Mar2021 | ₹13 Cr |
Mar2020 | ₹21 Cr |
How is Sundry Debtors of JAGSONPAL PHARMACEUTICALS Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2024 | ₹11 Cr | -47.53 | |
Mar2023 | ₹21 Cr | 33.99 | |
Mar2022 | ₹16 Cr | 23.00 | |
Mar2021 | ₹13 Cr | -40.97 | |
Mar2020 | ₹21 Cr | - |
Compare Sundry Debtors of peers of JAGSONPAL PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JAGSONPAL PHARMACEUTICALS | ₹1,447.5 Cr | 8.2% | -20.7% | 43% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹428,557.0 Cr | 2.3% | -0.8% | 32.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,994.0 Cr | 3.2% | 1.1% | 51.5% | Stock Analytics | |
CIPLA | ₹116,494.0 Cr | 0.3% | -2% | 10% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,297.0 Cr | -1.8% | 2.7% | 12.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,035.0 Cr | 2% | 1.5% | 38% | Stock Analytics |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JAGSONPAL PHARMACEUTICALS | 8.2% |
-20.7% |
43% |
SENSEX | -1% |
-5% |
5.6% |
You may also like the below Video Courses